4//SEC Filing
Berner Laura 4
Accession 0000950170-25-092940
CIK 0001641281other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:05 PM ET
Size
6.0 KB
Accession
0000950170-25-092940
Insider Transaction Report
Form 4
Berner Laura
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-27+1,100→ 1,100 totalExercise: $6.40Exp: 2035-05-26→ Common Stock (1,100 underlying)
Footnotes (2)
- [F1]On June 6, 2025, the Company effected a 1-for-20 reverse stock split of its common stock. All share and exercise price amounts reported herein reflect the reverse stock split. Prior to the reverse stock split, the reporting person was granted options to purchase 22,000 shares at an exercise price of $0.3200 per share.
- [F2]The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.
Documents
Issuer
Bolt Biotherapeutics, Inc.
CIK 0001641281
Entity typeother
Related Parties
1- filerCIK 0001958382
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:05 PM ET
- Size
- 6.0 KB